Company release
Nanoform Finland Plc
June 14, 2024
17.01 Finnish time / 16.01 Swedish time
Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström
Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s Member of the Board Albert Hæggström’s purchase of Nanoform Finland Plc shares:
Nanoform Finland Oyj – Managers’ Transactions
Person subject to the notification requirement
Name: Albert Hæggström
Position: Member of the Board/Deputy member
Issuer: Nanoform Finland Oyj
LEI: 743700JJO2NU8LBS1592
Notification type: INITIAL NOTIFICATION
Reference number: 65896/21/12
Transaction date: 2024-06-14
Outside a trading venue
Instrument type: SHARE
ISIN: FI4000330972
Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 14925 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 14925 Volume weighted average price: 0 EUR
For further information, please contact:
Peter Hänninen
General Counsel
+358 50 353 0408
For investor relations queries, please contact:
Henri von Haartman
Director of Investor Relations
+46 7686 650 11
About Nanoform
Nanoform is the medicine performance-enhancing company that leverages best-in-class innovative nanoparticle engineering technologies, expert formulation, and scalable GMP nano-API manufacturing to enable superior medicines for patients. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services, from pre-clinical to commercial scale. Nanoform will help improve bioavailability and drug delivery profiles, drive differentiation, patient adherence and extend the lifecycle potential of products. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 744 1900. For more information, please visit www.nanoform.com.